Ultra Early Cancer Screening (ctDNA by ddPCR)

NOTE: Doctor's prescription needed

Precise probe-based early screening using digital PCR technology for the most commonly present mutations and genes in almost all cancer types. The test in non-invasive and uses the extracted cell free DNA from the serum/plasma of the patient. It allows for an early detection of genetic anomalies in the patient's blood, which might indicated the risk of presence of cancer cells.

• Non-invasive and reliable early cancer detection
• Results in just 5-10 business days 
• Ultra-sensitive digital PCR technology with 99.99% accuracy